Lung cancer, Small cell lung cancer
Results
Phase 3
This trial looked at a drug called ipilimumab alongside chemotherapy for people recently diagnosed with small cell lung cancer (SCLC).
Everyone who took part had SCLC that had spread into the outside the lung or to other body organs. This is extensive stage SCLC.
Recruitment start: 1 December 2011
Recruitment end: 11 June 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Lorigan
Bristol-Myers Squibb
NIHR Clinical Research Network: Cancer
Last reviewed: 16 May 2017
CRUK internal database number: 9576
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
